Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Replimune Group, Inc.

Biological Products, (No Diagnostic Substances) · Woburn, MA, United States

  1. PrincipalsAndrew SchwendenmanChief Accounting OfficerChristopher SarchiChief Commercial OfficerEmily Luisa HillChief Financial Officerand 4 more
  2. CompanyReplimune Group, Inc.Woburn, MA, United States
  3. Phone line+1 (781) 222-9600General business
Request a quote

Replimune Group, Inc. is an SEC-registered Nasdaq-listed company (ticker REPL) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 7

Chief executive

Sushil PatelChief Executive Officer

Chair & board

Kapil DhingraDirector (Board)
Philip Astley-SparkeDirector (Board)

Finance

Andrew SchwendenmanChief Accounting Officer
Emily Luisa HillChief Financial Officer

Sales & commercial

Christopher SarchiChief Commercial Officer
Everyone else on file (1)
Konstantinos XynosChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Andrew Schwendenman — Chief Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Christopher Sarchi — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Emily Luisa Hill — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Konstantinos Xynos — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers